METHOD OF ISOLATION OF HIGH-MOLECULAR PROTEIN ACTIVATION COMPLEX OF HUMAN CASPASE-2 Russian patent published in 2018 - IPC G01N33/543 C12N15/64 C07K1/22 

Abstract RU 2671510 C1

FIELD: medicine.

SUBSTANCE: proposed group of inventions relates to medicine. Methods for isolating a high molecular weight protein complex for the activation of human caspase-2, formed in cancer cells in response to DNA-damaging chemotherapeutic treatment, are proposed. Cancer cells are incubated in the presence of a DNA-damaging chemotherapeutic drug until the maximum level of caspase-2 activation is obtained. Cells are harvested, followed by addition of a lysis buffer, separation of the cell debris from the lysate containing the high-molecular caspase-2 activation complex, separation by gel filtration of the resulting cell lysate, with the separation of fractions containing high-molecular forms of caspase-2 from fractions containing its monomeric forms and isolation from the fraction containing high-molecular forms of caspase-2, a high-molecular protein complex of caspase-2 activation.

EFFECT: proposed group of inventions provides an effective isolation of the complex of activation of human caspase-2.

36 cl, 5 tbl, 1 ex, 17 dwg

Similar patents RU2671510C1

Title Year Author Number
PROCASPASE 3 ACTIVATION BY COMBINATION THERAPY 2013
  • Khergenroter Pol Dzh.
  • Botem Rejchel Si.
  • Fen Timoti M.
  • Gilbert Mark Dzh.
  • Khendli Majkl K.
  • Tarasov Teodor M.
  • Rot Govard Es.
RU2659936C2
METHOD FOR OBTAINING CASPASE-3 2022
  • Granovskij Igor Eduardovich
  • Kalinin Danil Sergeevich
  • Majorov Sergej Gennadevich
  • Shlyapnikov Mikhail Grigorevich
  • Rabushko Elizaveta Nikolaevna
RU2792795C1
AGENT STIMULATING APOPTOSIS OF HUMAN LEUKAEMIA CELLS 2007
  • Fedorov Sergej Nikolaevich
  • Shubina Larisa Kimovna
  • Kapustina Irina Ivanovna
  • Avilov Sergej Anatol'Evich
  • Stonik Valentin Aronovich
  • Shastina Valerija Vladimirovna
  • Kvak Jang Jong
  • Park Dzhu In
  • Dzhin Dzhun O
  • Kvon Jang Khii
RU2360692C1
PROCASPASE COMBINED THERAPY WITH GLYBLASTOMA 2013
  • Paul J. Hergenrother,
  • Rachel C. Botham,
  • Timothy M. Fan,
  • Mark J. Gilbert,
  • Michael K. Handley,
  • Theodore M. Tarasow,
  • Avadhut Joshi,
  • Gregory J. Riggins,
RU2636234C2
COMPOSITION AND METHOD OF TUMOUR CURING 2007
  • Ogast Pol
  • Khuan Vaan Tszen
  • Natesan Shridaran
  • Liberman Sojan
RU2500815C2
PROAPOPTOSIS PROTEINS-CONTAINING THERAPEUTIC AGENTS 2002
  • Rozenbljum Majkl G.
  • Liu Jujing
RU2319709C2
APOPTOSIS DETECTION TECHNIQUES AND REAGENTS 2007
  • Ostin Kehri D.
  • Lorens Dehvid A.
  • Ashkenazi Avi
RU2450273C2
COMBINED THERAPY PAC-1 2016
  • Hergenrother Paul J.
  • Peh Jessie
RU2720509C2
INDUCTION OF APOPTOSIS IN TUMOUR CELLS, EXPRESSING TOLL-LIKE RECEPTOR 2005
  • Lebek Serzh
  • Renno Tufik
  • Salon Brjuno
  • Kost-Invernitstsi Izabel'
  • Rissoan Mari-Klotil'D
RU2401661C9
ANALYSES AND METHODS OF BIOMARKER APPLICATION 2006
  • Vagner Klaus V.
  • Ashkenazi Avi Dzh.
RU2409817C2

RU 2 671 510 C1

Authors

Kopeina Gelina Sergeevna

Zamaraev Aleksej Vladimirovich

Lavrik Inna Nikolaevna

Zhivotovskij Boris Davidovich

Dates

2018-11-01Published

2016-06-29Filed